FDA-Drug2026-10-14Class IIPROCESSING DEFECT

Carolina Infusion tirzepatide/cyanocobalamin injectable recalled for sterility concerns

OTHERNationwide distributionDrugsBaby & kids

What this means

Carolina Infusion, LLC has recalled tirzepatide/cyanocobalamin injectable syringes due to concerns that the sterility of the product cannot be assured. The issue is related to the use of bacteriostatic water in the formulation and processing equipment used to prepare the compounded medication. Three specific lots distributed nationwide are affected.

  • If you have received this medication, contact your prescriber or healthcare provider immediately.
  • Do not use the affected lots: 08032026@23 (BUD 9/17/2026), 08172026@19 (BUD 10/1/2026), or 08262026@13 (BUD 10/10/2026).
  • Return any unused syringes to your pharmacy or healthcare provider.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
24.8 mLs -in patient specific syringe dose
Manufactured in
95 Bees Creek Rd, N/A, Ridgeland, SC, United States
Products
TIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0029-2027

More Carolina Infusion recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.